Veradermics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veradermics and other ETFs, options, and stocks.About MANE
Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions.
CEOReid Waldman
CEOReid Waldman
Employees—
Employees—
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2019
Founded2019
Employees—
Employees—
MANE Key Statistics
Market cap1.97B
Market cap1.97B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume260.67K
Average volume260.67K
High today$54.65
High today$54.65
Low today$51.84
Low today$51.84
Open price$52.23
Open price$52.23
Volume277.12K
Volume277.12K
52 Week high$57.08
52 Week high$57.08
52 Week low$17.00
52 Week low$17.00
Stock Snapshot
As of today, Veradermics(MANE) shares are valued at $53.60. The company's market cap stands at 1.97B.
On 2026-03-14, Veradermics(MANE) stock moved within a range of $51.84 to $54.65. With shares now at $53.60, the stock is trading +3.4% above its intraday low and -1.9% below the session's peak.
Trading volume for Veradermics(MANE) stock has reached 277.12K, versus its average volume of 260.67K.
Over the past 52 weeks, Veradermics(MANE) stock has traded between a high of $57.08 and a low of $17.00.
Over the past 52 weeks, Veradermics(MANE) stock has traded between a high of $57.08 and a low of $17.00.
People also own
Based on the portfolios of people who own MANE. This list is generated using Robinhood data, and it’s not a recommendation.